Cargando…

Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis

BACKGROUND: From January 2020 to December 2022, China implemented “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” to block the COVID-19 epidemic; however, the immediate and long-term impact of three strategies on other infectious diseases and the difference in their impact is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Tianshan, Zhang, Xiaoshu, Meng, Lei, Li, Donghua, Jin, Na, Zhao, Xin, Zheng, Hongmiao, Wang, Tingrong, Li, Rui, Ren, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354895/
https://www.ncbi.nlm.nih.gov/pubmed/37464368
http://dx.doi.org/10.1186/s12889-023-16318-y
_version_ 1785075019834982400
author Shi, Tianshan
Zhang, Xiaoshu
Meng, Lei
Li, Donghua
Jin, Na
Zhao, Xin
Zheng, Hongmiao
Wang, Tingrong
Li, Rui
Ren, Xiaowei
author_facet Shi, Tianshan
Zhang, Xiaoshu
Meng, Lei
Li, Donghua
Jin, Na
Zhao, Xin
Zheng, Hongmiao
Wang, Tingrong
Li, Rui
Ren, Xiaowei
author_sort Shi, Tianshan
collection PubMed
description BACKGROUND: From January 2020 to December 2022, China implemented “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” to block the COVID-19 epidemic; however, the immediate and long-term impact of three strategies on other infectious diseases and the difference in their impact is currently unknown. We aim to provide a more comprehensive understanding of the impact of non-pharmacological interventions (NPIs) on infectious diseases in China. METHODS: We collected data on the monthly case count of infectious diseases in China from January 2015 to July 2022. After considering long-term trends using the Cox-Stuart test, we performed the two ratio Z tests to preliminary analyze the impact of three strategies on infectious diseases. Next, we used a multistage interrupted-time-series analysis fitted by the Poisson regression to evaluate and compare the immediate and long-term impact of three strategies on infectious diseases in China. RESULTS: Compared to before COVID-19, the incidence of almost all infectious diseases decreased immediately at stages 1, 2, and 3; meanwhile, the slope in the incidence of many infectious diseases also decreased at the three stages. However, the slope in the incidence of all sexually transmitted diseases increased at stage 1, the slope in the incidence of all gastrointestinal infectious diseases increased at stage 2, and the slope in the incidence of some diseases such as pertussis, influenza, and brucellosis increased at stage 3. The immediate and long-term limiting effects of “Normalized-control” on respiratory-transmitted diseases were weaker than “First-level-response” and the long-term limiting effects of “Dynamic-COVID-zero” on pertussis, influenza, and hydatid disease were weaker than “Normalized-control”. CONCLUSIONS: Three COVID-19 control strategies in China have immediate and long-term limiting effects on many infectious diseases, but there are differences in their limiting effects. Evidence from this study shows that pertussis, influenza, brucellosis, and hydatid disease began to recover at stage 3, and relaxation of NPIs may lead to the resurgence of respiratory-transmitted diseases and vector-borne diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16318-y.
format Online
Article
Text
id pubmed-10354895
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103548952023-07-20 Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis Shi, Tianshan Zhang, Xiaoshu Meng, Lei Li, Donghua Jin, Na Zhao, Xin Zheng, Hongmiao Wang, Tingrong Li, Rui Ren, Xiaowei BMC Public Health Research BACKGROUND: From January 2020 to December 2022, China implemented “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” to block the COVID-19 epidemic; however, the immediate and long-term impact of three strategies on other infectious diseases and the difference in their impact is currently unknown. We aim to provide a more comprehensive understanding of the impact of non-pharmacological interventions (NPIs) on infectious diseases in China. METHODS: We collected data on the monthly case count of infectious diseases in China from January 2015 to July 2022. After considering long-term trends using the Cox-Stuart test, we performed the two ratio Z tests to preliminary analyze the impact of three strategies on infectious diseases. Next, we used a multistage interrupted-time-series analysis fitted by the Poisson regression to evaluate and compare the immediate and long-term impact of three strategies on infectious diseases in China. RESULTS: Compared to before COVID-19, the incidence of almost all infectious diseases decreased immediately at stages 1, 2, and 3; meanwhile, the slope in the incidence of many infectious diseases also decreased at the three stages. However, the slope in the incidence of all sexually transmitted diseases increased at stage 1, the slope in the incidence of all gastrointestinal infectious diseases increased at stage 2, and the slope in the incidence of some diseases such as pertussis, influenza, and brucellosis increased at stage 3. The immediate and long-term limiting effects of “Normalized-control” on respiratory-transmitted diseases were weaker than “First-level-response” and the long-term limiting effects of “Dynamic-COVID-zero” on pertussis, influenza, and hydatid disease were weaker than “Normalized-control”. CONCLUSIONS: Three COVID-19 control strategies in China have immediate and long-term limiting effects on many infectious diseases, but there are differences in their limiting effects. Evidence from this study shows that pertussis, influenza, brucellosis, and hydatid disease began to recover at stage 3, and relaxation of NPIs may lead to the resurgence of respiratory-transmitted diseases and vector-borne diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16318-y. BioMed Central 2023-07-18 /pmc/articles/PMC10354895/ /pubmed/37464368 http://dx.doi.org/10.1186/s12889-023-16318-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shi, Tianshan
Zhang, Xiaoshu
Meng, Lei
Li, Donghua
Jin, Na
Zhao, Xin
Zheng, Hongmiao
Wang, Tingrong
Li, Rui
Ren, Xiaowei
Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis
title Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis
title_full Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis
title_fullStr Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis
title_full_unstemmed Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis
title_short Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis
title_sort immediate and long-term changes in infectious diseases in china at the “first-level-response”, “normalized-control” and “dynamic-covid-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354895/
https://www.ncbi.nlm.nih.gov/pubmed/37464368
http://dx.doi.org/10.1186/s12889-023-16318-y
work_keys_str_mv AT shitianshan immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT zhangxiaoshu immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT menglei immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT lidonghua immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT jinna immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT zhaoxin immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT zhenghongmiao immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT wangtingrong immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT lirui immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis
AT renxiaowei immediateandlongtermchangesininfectiousdiseasesinchinaatthefirstlevelresponsenormalizedcontrolanddynamiccovidzerostagesfrom2020to2022amultistageinterruptedtimeseriesanalysis